Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212305 | SCV000167442 | benign | not specified | 2014-02-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000410388 | SCV000404612 | likely benign | Fanconi anemia complementation group J | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Counsyl | RCV000410388 | SCV000489859 | benign | Fanconi anemia complementation group J | 2016-07-05 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000411896 | SCV000489860 | benign | Ovarian neoplasm | 2016-07-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000124033 | SCV000537403 | benign | Hereditary cancer-predisposing syndrome | 2015-04-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001701759 | SCV001471390 | benign | not provided | 2021-09-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002055434 | SCV002407192 | benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-02-01 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225404 | SCV002505042 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000212305 | SCV002551196 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149854 | SCV003837713 | benign | Breast and/or ovarian cancer | 2021-07-05 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315842 | SCV004016919 | benign | Familial cancer of breast | 2023-07-07 | criteria provided, single submitter | clinical testing | |
University of Washington Department of Laboratory Medicine, |
RCV000124033 | SCV000265069 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-01 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001356961 | SCV001552267 | benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The BRIP1 r.(spl?) variant was identified in 9 of 714 proband chromosomes (frequency: 0.01) from individuals or families with breast cancer and was not identified in 1728 control chromosomes from healthy individuals (Cao 2009). The variant was also identified in dbSBP (ID: rs117820198) as other, ClinVar and Clinvitae (benign by Counsyl, Color Genomics, GeneDx; and likely benign by Illumina and University of Washington), Zhejiang Colon Cancer Database (1x as unknown) databases. The variant was not identified in Cosmic or MutDB databases. The variant was also identified by our laboratory in 1 individuals with breast cancer who is of Asian descent. The variant was identified in control databases in 777 of 276108 chromosomes (11 homozygous individuals) at a frequency of 0.003 increasing the likelihood that this may be a low frequency benign variant in certain populations of origin (Genome Aggregation Consortium Feb 27, 2017). The variant was identified in the following populations at a frequency greater than 1%: East Asian in 751 of 18858 chromosomes (freq: 0.04). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. | |
Genome Diagnostics Laboratory, |
RCV000212305 | SCV001808685 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701759 | SCV001928395 | likely benign | not provided | no assertion criteria provided | clinical testing |